ALVGO Fundamental Analysis - VOGO SACA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALVGO. ALVGO was compared to 114 industry peers in the Software industry. ALVGO may be in some trouble as it scores bad on both profitability and health. ALVGO is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALVGO has reported negative net income.

ALVGO had a negative operating cash flow in the past year.

ALVGO had negative earnings in each of the past 5 years.

ALVGO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ALVGO has a Return On Assets of -7.50%. This is in the lower half of the industry: ALVGO underperforms 77.19% of its industry peers.

ALVGO's Return On Equity of -15.00% is on the low side compared to the rest of the industry. ALVGO is outperformed by 71.93% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.5%
ROE	-15%
ROIC	N/A

ROA(3y)-8.38%

ROA(5y)-9.73%

ROE(3y)-20.53%

ROE(5y)-23.28%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALVGO has a Gross Margin of 57.07%. This is in the lower half of the industry: ALVGO underperforms 64.04% of its industry peers.

In the last couple of years the Gross Margin of ALVGO has grown nicely.

The Profit Margin and Operating Margin are not available for ALVGO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	57.07%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y22.4%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALVGO does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALVGO has been increased compared to 1 year ago.

Compared to 5 years ago, ALVGO has more shares outstanding

ALVGO has a worse debt/assets ratio than last year.

2.2 Solvency

ALVGO has an Altman-Z score of 0.89. This is a bad value and indicates that ALVGO is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.89, ALVGO is not doing good in the industry: 71.93% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.44 indicates that ALVGO is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.44, ALVGO is doing worse than 60.53% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	N/A
Altman-Z	0.89

ROIC/WACCN/A

WACC8.09%

2.3 Liquidity

ALVGO has a Current Ratio of 1.86. This is a normal value and indicates that ALVGO is financially healthy and should not expect problems in meeting its short term obligations.

ALVGO's Current ratio of 1.86 is fine compared to the rest of the industry. ALVGO outperforms 69.30% of its industry peers.

ALVGO has a Quick Ratio of 1.03. This is a normal value and indicates that ALVGO is financially healthy and should not expect problems in meeting its short term obligations.

ALVGO has a Quick ratio of 1.03. This is in the lower half of the industry: ALVGO underperforms 66.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.86
Quick Ratio	1.03

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALVGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -121.74%.

The Revenue has decreased by -4.60% in the past year.

Measured over the past years, ALVGO shows a very strong growth in Revenue. The Revenue has been growing by 42.80% on average per year.

EPS 1Y (TTM)-121.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-255.56%

Revenue 1Y (TTM)-4.6%

Revenue growth 3Y7.48%

Revenue growth 5Y42.8%

Sales Q2Q%-5.7%

3.2 Future

ALVGO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.19% yearly.

The Revenue is expected to grow by 7.06% on average over the next years.

EPS Next Y31.43%

EPS Next 2Y18.92%

EPS Next 3Y15.19%

EPS Next 5YN/A

Revenue Next Year0%

Revenue Next 2Y4.45%

Revenue Next 3Y7.06%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALVGO. In the last year negative earnings were reported.

Also next year ALVGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALVGO's earnings are expected to grow with 15.19% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y18.92%

EPS Next 3Y15.19%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALVGO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

VOGO SACA

EPA:ALVGO (1/8/2026, 7:00:00 PM)

2.5

-0.07 (-2.72%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)09-24 2025-09-24

Earnings (Next)02-03 2026-02-03

Inst Owners3.73%

Inst Owner ChangeN/A

Ins Owners5.71%

Ins Owner ChangeN/A

Market Cap15.32M

Revenue(TTM)10.28M

Net Income(TTM)-1.80M

Analysts84

Price Target2.81 (12.4%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)3.38%

PT rev (3m)3.38%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-140%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.45
P/FCF	N/A
P/OCF	N/A
P/B	1.28
P/tB	7.66
EV/EBITDA	N/A

EPS(TTM)-0.51

EYN/A

EPS(NY)-0.21

Fwd EYN/A

FCF(TTM)-0.64

FCFYN/A

OCF(TTM)-0.29

OCFYN/A

SpS1.73

BVpS1.96

TBVpS0.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.5%
ROE	-15%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	57.07%
FCFM	N/A

ROA(3y)-8.38%

ROA(5y)-9.73%

ROE(3y)-20.53%

ROE(5y)-23.28%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y22.4%

GM growth 5YN/A

F-Score5

Asset Turnover0.44

Health

		Industry Rank	Sector Rank
Debt/Equity	0.44
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	154.75%
Cap/Sales	19.99%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.86
Quick Ratio	1.03
Altman-Z	0.89

F-Score5

WACC8.09%

ROIC/WACCN/A

Cap/Depr(3y)200.78%

Cap/Depr(5y)198.31%

Cap/Sales(3y)20.86%

Cap/Sales(5y)19.16%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-121.74%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-255.56%

EPS Next Y31.43%

EPS Next 2Y18.92%

EPS Next 3Y15.19%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.6%

Revenue growth 3Y7.48%

Revenue growth 5Y42.8%

Sales Q2Q%-5.7%

Revenue Next Year0%

Revenue Next 2Y4.45%

Revenue Next 3Y7.06%

Revenue Next 5YN/A

EBIT growth 1Y0.39%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year133.33%

EBIT Next 3Y35.72%

EBIT Next 5YN/A

FCF growth 1Y29.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y45.43%

OCF growth 3YN/A

OCF growth 5YN/A

VOGO SACA / ALVGO.PA FAQ

Can you provide the ChartMill fundamental rating for VOGO SACA?

ChartMill assigns a fundamental rating of 2 / 10 to ALVGO.PA.

What is the valuation status of VOGO SACA (ALVGO.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to VOGO SACA (ALVGO.PA). This can be considered as Overvalued.

What is the profitability of ALVGO stock?

VOGO SACA (ALVGO.PA) has a profitability rating of 1 / 10.

VOGO SACA (ALVGO.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

VOGO SACA / ALVGO.PA FAQ

Can you provide the ChartMill fundamental rating for VOGO SACA?

What is the valuation status of VOGO SACA (ALVGO.PA) stock?

What is the profitability of ALVGO stock?